Total Payments
$10,606
2024 Payments
$839.33
Companies
31
Transactions
438
Medicare Patients
17,321
Medicare Billing
$3.5M
Payment Breakdown by Category
Food & Beverage$9,049 (85.3%)
Travel$1,343 (12.7%)
Education$213.95 (2.0%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,049 | 429 | 85.3% |
| Travel and Lodging | $1,343 | 5 | 12.7% |
| Education | $213.95 | 4 | 2.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Abbott Laboratories | $3,417 | 87 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $1,072 | 55 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $832.29 | 18 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $830.73 | 45 | $0 (2024) |
| Merck Sharp & Dohme LLC | $593.01 | 34 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $579.42 | 35 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $549.53 | 36 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $377.68 | 17 | $0 (2019) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $364.55 | 16 | $0 (2024) |
| Boston Scientific Corporation | $318.27 | 14 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $839.33 | 33 | Actelion Pharmaceuticals US, Inc. ($279.91) |
| 2023 | $840.59 | 45 | Merck Sharp & Dohme LLC ($211.68) |
| 2022 | $798.94 | 46 | E.R. Squibb & Sons, L.L.C. ($161.85) |
| 2021 | $616.46 | 38 | Merck Sharp & Dohme Corporation ($188.46) |
| 2020 | $408.34 | 26 | Janssen Pharmaceuticals, Inc ($173.34) |
| 2019 | $1,082 | 60 | Janssen Pharmaceuticals, Inc ($215.77) |
| 2018 | $4,116 | 103 | Abbott Laboratories ($2,677) |
| 2017 | $1,904 | 87 | Abbott Laboratories ($392.70) |
All Payment Transactions
438 individual payment records from CMS Open Payments — Page 1 of 18
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Food and Beverage | In-kind items and services | $19.96 | General |
| Category: Cardiology | ||||||
| 12/04/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $19.49 | General |
| Category: Cardiovascular | ||||||
| 11/20/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Education | In-kind items and services | $94.99 | General |
| Category: Cardiology | ||||||
| 11/06/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Food and Beverage | In-kind items and services | $20.72 | General |
| Category: Cardiology | ||||||
| 10/23/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $25.84 | General |
| Category: Cardiovascular | ||||||
| 10/16/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $33.61 | General |
| Category: DIABETES | ||||||
| 10/14/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Food and Beverage | In-kind items and services | $20.14 | General |
| Category: Cardiology | ||||||
| 10/09/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $21.48 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/18/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $9.21 | General |
| Category: Cardiovascular | ||||||
| 09/16/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Food and Beverage | In-kind items and services | $17.70 | General |
| Category: Cardiology | ||||||
| 09/13/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $22.68 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 09/04/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $23.38 | General |
| Category: DIABETES | ||||||
| 08/19/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $9.49 | General |
| Category: Cardiovascular | ||||||
| 08/14/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Food and Beverage | In-kind items and services | $20.06 | General |
| Category: Cardiology | ||||||
| 08/12/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $14.23 | General |
| Category: Obesity | ||||||
| 08/07/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $18.18 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/29/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $17.93 | General |
| Category: Cardiovascular | ||||||
| 07/22/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $17.44 | General |
| Category: Cardiovascular | ||||||
| 07/03/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Food and Beverage | In-kind items and services | $21.49 | General |
| Category: Cardiology | ||||||
| 06/26/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.67 | General |
| Category: DIABETES | ||||||
| 06/07/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $15.43 | General |
| Category: Cardiovascular | ||||||
| 05/23/2024 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Heart Failure | ||||||
| 05/20/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Food and Beverage | In-kind items and services | $22.29 | General |
| Category: Cardiology | ||||||
| 05/14/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $17.07 | General |
| Category: Cardiovascular | ||||||
| 05/01/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $21.84 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 23 | 3,901 | 5,138 | $2.3M | $739,334 |
| 2022 | 26 | 4,259 | 5,670 | $2.5M | $825,084 |
| 2021 | 27 | 4,414 | 5,876 | $2.7M | $889,862 |
| 2020 | 22 | 4,747 | 6,399 | $3.0M | $1.0M |
Total Patients
17,321
Total Services
23,083
Medicare Billing
$3.5M
Procedure Codes
105
All Medicare Procedures & Services
105 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 78492 | Nuclear medicine studies of blood flow in heart muscle at rest and with stress | Office | 2023 | 343 | 344 | $1.1M | $362,133 | 33.9% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 562 | 586 | $331,902 | $82,140 | 24.7% |
| A9555 | Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | Office | 2023 | 343 | 351 | $88,408 | $68,960 | 78.0% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 360 | 1,444 | $200,640 | $62,313 | 31.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 424 | 467 | $120,019 | $39,206 | 32.7% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 389 | 390 | $70,200 | $18,967 | 27.0% |
| 93229 | Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | Office | 2023 | 30 | 30 | $60,900 | $18,891 | 31.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 220 | 220 | $56,540 | $16,901 | 29.9% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 270 | 289 | $57,969 | $15,094 | 26.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 256 | 260 | $45,240 | $15,038 | 33.2% |
| 78451 | Nuclear medicine study of heart muscle at rest and with stress and spect | Office | 2023 | 45 | 45 | $36,540 | $9,375 | 25.7% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 57 | 60 | $29,640 | $7,929 | 26.8% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 32 | 32 | $28,896 | $5,123 | 17.7% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 44 | 45 | $15,075 | $4,403 | 29.2% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 32 | 32 | $17,424 | $4,151 | 23.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 282 | 313 | $15,650 | $3,056 | 19.5% |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 2023 | 46 | 46 | $20,022 | $1,975 | 9.9% |
| 93312 | Ultrasound of heart with probe in esophagus, with report | Facility | 2023 | 18 | 18 | $5,364 | $1,465 | 27.3% |
| 93288 | Evaluation of single, dual, multiple lead or leadless pacemaker system | Office | 2023 | 35 | 53 | $3,339 | $746.98 | 22.4% |
| 93228 | Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | Office | 2023 | 30 | 30 | $2,280 | $571.01 | 25.0% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Facility | 2023 | 37 | 37 | $1,332 | $350.39 | 26.3% |
| 93308 | Ultrasound of heart, follow-up | Facility | 2023 | 16 | 16 | $4,528 | $304.48 | 6.7% |
| 93320 | Ultrasound of heart blood flow, valves and chambers | Facility | 2023 | 15 | 15 | $795.00 | $203.70 | 25.6% |
| 93325 | Ultrasound of heart with color-depicted blood flow, rate and valve function | Facility | 2023 | 15 | 15 | $165.00 | $35.55 | 21.5% |
| 78492 | Nuclear medicine studies of blood flow in heart muscle at rest and with stress | Office | 2022 | 361 | 363 | $1.1M | $385,732 | 34.2% |
About Dr. Ajay Gaalla, MD
Dr. Ajay Gaalla, MD is a Cardiovascular Disease healthcare provider based in Victoria, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/10/2006. The National Provider Identifier (NPI) number assigned to this provider is 1104837772.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ajay Gaalla, MD has received a total of $10,606 in payments from pharmaceutical and medical device companies, with $839.33 received in 2024. These payments were reported across 438 transactions from 31 companies. The most common payment nature is "Food and Beverage" ($9,049).
As a Medicare-enrolled provider, Gaalla has provided services to 17,321 Medicare beneficiaries, totaling 23,083 services with total Medicare billing of $3.5M. Data is available for 4 years (2020–2023), covering 105 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Victoria, TX
- Active Since 08/10/2006
- Last Updated 08/25/2022
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1104837772
Products in Payments
- CardioMEMS HF System (Device) $2,521
- XARELTO (Drug) $1,052
- ENTRESTO (Drug) $655.98
- JARDIANCE (Drug) $634.25
- VERQUVO (Drug) $593.01
- BRILINTA (Drug) $498.44
- ELIQUIS (Drug) $409.36
- LifeVest (Device) $364.55
- OPSUMIT (Drug) $296.58
- PRALUENT (Drug) $248.71
- PRADAXA (Drug) $198.04
- Corlanor (Drug) $196.91
- LEQVIO (Drug) $174.75
- CARDIOMEMS (Device) $169.07
- NORTHERA (Drug) $160.32
- Assurity Pacemaker (Device) $157.78
- Merlin Connectivity and Remote (Device) $148.22
- CAMZYOS (Drug) $142.42
- XIFAXAN (Drug) $134.51
- Impella (Device) $125.24
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.